FrontPage is India's Stock Market Social Network
Join 3,00,000+ Traders and Investors
JBCHEPHARM
10123456789,901234567891012345678940123456789.4012345678900123456789
+23.55 (+1.25%)
Previous Close: 1890.85
1D
5D
1M
3M
1Y
5Y
Popular Posts
See All

TechMentalAK

Nirmal Bang target on JBCHEPHARM Date: 12-Jan-22 Broker: Nirmal Bang Price @ Call: 1708 Target: 1974 Potential: 15.57% Recommendation: BUY

ReportBot

TradePeCharcha

**Result Highlights** Coal India Ltd.: Net Revenue at Rs. 26700.1 crore, Rs. 27568.2 crore YoY, Rs. 23686.0 crore QoQ (-3.1% YoY, +12.7% QoQ). EBITDA at Rs. 6382.1 crore, Rs. 6389.3 crore YoY, Rs. 5164.8 crore QoQ (-0.1% YoY, +23.6% QoQ). EBITDA Margin at 23.9%, +73 bps YoY and +210 bps QoQ. Net Profit at Rs. 4589.0 crore, Rs. 4625.8 crore YoY, Rs. 3084.1 crore QoQ (-0.8% YoY, +48.8% QoQ). Indian Overseas Bank: NII at Rs. 1405.2 crore, Rs. 1531.8 crore YoY, Rs. 1521.7 crore QoQ (-8.3% YoY, -7.7% QoQ). Net Profit at Rs. 349.8 crore, Rs. 90.5 crore YoY, Rs. 212.9 crore QoQ (+286.6% YoY, +64.3% QoQ). GNPA at 11.69%, Vs 14.78% YoY and 12.19% QoQ. NNPA at 3.58%, Vs 5.44% YoY and 3.13% QoQ. Kajaria Ceramics Ltd.: Net Revenue at Rs. 952.5 crore, Rs. 652.0 crore YoY, Rs. 838.3 crore QoQ (+46.1% YoY, +13.6% QoQ). EBITDA at Rs. 190.9 crore, Rs. 93.4 crore YoY, Rs. 181.8 crore QoQ (+104.5% YoY, +5% QoQ). EBITDA Margin at 20%, +573 bps YoY and +-164 bps QoQ. Net Profit at Rs. 131.4 crore, Rs. 48.8 crore YoY, Rs. 121.0 crore QoQ (+169.1% YoY, +8.6% QoQ). JB Chemicals & Pharmaceuticals Ltd.: Net Revenue at Rs. 528.5 crore, Rs. 443.6 crore YoY, Rs. 548.2 crore QoQ (+19.1% YoY, -3.6% QoQ). EBITDA at Rs. 123.9 crore, Rs. 91.7 crore YoY, Rs. 171.0 crore QoQ (+35.1% YoY, -27.5% QoQ). EBITDA Margin at 23.4%, +276 bps YoY and +-775 bps QoQ. Net Profit at Rs. 100.8 crore, Rs. 50.1 crore YoY, Rs. 154.3 crore QoQ (+101.3% YoY, -34.7% QoQ). IDFC Ltd.: Net Revenue at Rs. 127.8 crore, Rs. 47.1 crore YoY, Rs. 103.8 crore QoQ (+171.5% YoY, +23.1% QoQ). EBITDA at Rs. 65.3 crore, Rs. -23.5 crore YoY, Rs. 52.8 crore QoQ. EBITDA Margin at 51.1%, +10094 bps YoY and +21 bps QoQ. Net Profit at Rs. 42.0 crore, Rs. -242.4 crore YoY, Rs. -205.6 crore QoQ. Ashika Responsive Industries Ltd.: Net Revenue at Rs. 207.3 crore, Rs. 111.1 crore YoY, Rs. 202.9 crore QoQ (+86.6% YoY, +2.2% QoQ). EBITDA at Rs. 30.7 crore, Rs. 10.3 crore YoY, Rs. 46.3 crore QoQ (+199.5% YoY, -33.6% QoQ). EBITDA Margin at 14.8%, +559 bps YoY and +-799 bps QoQ. Net Profit at Rs. 11.8 crore, Rs. -4.2 crore YoY, Rs. -10.4 crore QoQ. Greenply Industries Ltd.: Net Revenue at Rs. 396.7 crore, Rs. 344.7 crore YoY, Rs. 340.4 crore QoQ (+15.1% YoY, +16.5% QoQ). EBITDA at Rs. 45.5 crore, Rs. 29.9 crore YoY, Rs. 41.7 crore QoQ (+52.3% YoY, +9% QoQ). EBITDA Margin at 11.5%, +280 bps YoY and +-79 bps QoQ. Net Profit at Rs. 28.6 crore, Rs. -21.5 crore YoY, Rs. 25.0 crore QoQ (+14.6% QoQ). #COALINDIA #GREENPLY #IDFC #JBCHEPHARM #IOB

TradeAdda

https://www.moneycontrol.com/news/business/markets/top-10-stocks-to-look-at-based-on-warren-buffetts-investment-methodology-5773561.html #ABBOTINDIA #ALKYLAMINE #AMRUTANJAN #BRITANNIA #JBCHEPHARM

NewsBot

Ravi

JB CHEMICAL HIGH 383+ #JBCHEPHARM

Halal Investment

JB CHEMICAL...375+ ACHV SHRTTERM TARGET...❣ #JBCHEPHARM

Halal Investment

NewsBot-display-image
Reputation: 27,588  •  Jul 19 10:08 AM
Buy J.B. Chemicals and Pharmaceuticals; target of Rs 1950: Prabhudas Lilladher
Prabhudas Lilladher is bullish on J.B. Chemicals and Pharmaceuticals has recommended buy rating on the stock with a target price of Rs 1950 in its research report dated July 19, 2022.
Moneycontrol
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,588  •  May 30 5:16 AM
Buy J B Chemicals & Pharmaceuticals, target price Rs 1896: ICICI Securities
J B Chemicals & Pharmaceuticals Ltd., incorporated in the year 1976, is a Mid Cap company (having a market cap of Rs 12820.33 Crore) operating in Pharmaceuticals sector.
The Economic Times
Like
Comment
Share
Add a comment
ResultsBot-display-image
Reputation: 21,715  •  May 24 12:30 PM

#JBCHEPHARM will declare results on May 26, 2022
Do you have any view on the results? Let's aggregate whatever information we have from other sources for everyone's benefit.
Like
Comment
Share
Add a comment
TechMentalAK-display-image
Reputation: 12,302  •  Apr 26 3:54 AM

JB Chemicals & Pharma
Daily Timeframe
1️⃣ Potential Breakout Candidate
2️⃣ Might break above consolidation zone & trendline
3️⃣ Important levels marked on the chart
⭐ CMP 1760
DYOR
JBCHEPHARM - chart - 8905798
2 Likes
Comment
Share
Add a comment
ReportBot-display-image
Reputation: 41,320  •  Feb 25 7:30 AM

Nirmal Bang target on JBCHEPHARM
Date: 25-Feb-22 Broker: Nirmal Bang Price @ Call: 1584 Target: 1988 Potential: 25.51% Recommendation: BUY
1 Like
Comment
Share
Add a comment
ReportBot-display-image
Reputation: 41,320  •  Feb 16 7:30 AM

Nirmal Bang target on JBCHEPHARM
Date: 16-Feb-22 Broker: Nirmal Bang Price @ Call: 1619 Target: 1988 Potential: 22.79% Recommendation: BUY
1 Like
Comment
Share
Add a comment
ResultsBot-display-image
Reputation: 21,715  •  Feb 12 12:30 PM

#JBCHEPHARM will declare results on Feb 14, 2022
Do you have any view on the results? Let's aggregate whatever information we have from other sources for everyone's benefit.
Like
Comment
Share
Add a comment
Shyamkumar S-display-image
Reputation: 17,795  •  Feb 7 2:15 AM
Like
Comment
Share
Add a comment
Spoiledbrahmin-display-image
Reputation: 1,198  •  Jan 29 2:38 AM

12 brands have been acquired, revenue acquired is at ₹160 cr. Probiotic market is around ₹1,800 cr. Have a lot of synergies in place. Gross margin is close to 70%, says Nikhil Chopra of #JBCHEPHARM
Like
Comment
Share
Add a comment
Spoiledbrahmin-display-image
Reputation: 1,198  •  Jan 28 1:23 AM

#JBCHEPHARM The acquisition will mark JBCPL’s entry into the fast-growing probiotics, therapeutic nutraceuticals and reproductive health market with attractive set
of brands
• Will be amongst the top five probiotics players in the country, in a segment which is growing at aro......read more
Like
Comment
Share
Add a comment
Spoiledbrahmin-display-image
Reputation: 1,198  •  Jan 28 1:22 AM

TO ACQUIRE BRANDS FROM SANZYME, A LEADING PLAYER IN THE PROBIOTICS SEGMENT FOR A TRANSACTION VALUE OF ₹628 CR
Like
Comment
Share
Add a comment
ReportBot-display-image
Reputation: 41,320  •  Jan 13 8:30 AM

Nirmal Bang target on JBCHEPHARM
Date: 12-Jan-22 Broker: Nirmal Bang Price @ Call: 1708 Target: 1974 Potential: 15.57% Recommendation: BUY
3 Likes
Comment
Share
Add a comment
Profit Raja-display-image
Reputation: 1,648  •  Dec 24, 2021 2:25 AM

Intrqday stock
Buy above 1700
Target 1720/25/35/
Like
Comment
Share
Add a comment
Intraday Traders FnO-display-image
Reputation: 3,672  •  Dec 24, 2021 7:22 AM
Like
Comment
Share
Add a comment
Harry-display-image
Reputation: 1,905  •  Nov 12, 2021 4:13 AM

*Correction* *JB Chemicals & Pharmaceuticals Ltd.* | *CMP* Rs. 1657 | *M Cap* Rs. 12806 Cr | *52 W H/L* 1985/883
(Nirmal Bang Retail Research)
*Result is inline with expectations*
Revenue from Operations came at Rs. 593 Cr (-2.1% QoQ, 33.7% YoY) vs expectation of Rs. 567.1 Cr, Qo......read more
Like
Comment
Share
Add a comment
ResultsBot-display-image
Reputation: 21,715  •  Nov 9, 2021 12:30 PM

#JBCHEPHARM will declare results on Nov 11, 2021
Do you have any view on the results? Let's aggregate whatever information we have from other sources for everyone's benefit.
Like
Comment
Share
Add a comment
Shyamkumar S-display-image
Reputation: 17,795  •  Sep 29, 2021 8:31 AM
Shyamkumar S in JBCHEPHARM
Swing Trade : Buy #JBCHEPHARM at 1835 For Targe...

Book Profit 1835 to 1955 All Target Hit Book Profit Join Us For Profitable Journey #JBCHEPHARM
JBCHEPHARM - chart - 4947756
Like
Comment
Share
Add a comment